-
1 Comment
Tianjin Chase Sun Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 2.2% below its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Tianjin Chase Sun Pharmaceutical Co.,Ltd's total revenue rose by 27.0% to $2B since the same quarter in the previous year.
Its net income has increased by 77.4% to $-26M since the same quarter in the previous year.
Finally, its free cash flow grew by 167.5% to $156M since the same quarter in the previous year.
Based on the above factors, Tianjin Chase Sun Pharmaceutical Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100000GF1 |
| Market Cap | 10B |
|---|---|
| Dividend Yield | 0.8% |
| PE Ratio | 55.83 |
| Target Price | 4 |
| Beta | 0.09 |
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, medical and healthcare services, and smart supply chain for pharmaceutical and medical devices. It also provides its products in the areas of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases, as well as anti-tumor. Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300026.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
